Skip to content

Amgen is said to agree to buy horizon at $26 billion valuation

The US biotechnology giant offered around $116.5 for each Horizon share, said the person, who asked not to be identified as the information is private. The offer price is at a around 20% premium to Horizon’s closing price of $97.29 on Friday.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish